BG103238A - РТХ-ЧУВСТВИТЕЛНИ g-ПРОТЕИНИ, МЕТОД ЗА ТЯХНОТО ПРОИЗВОДСТВО И ПРИЛОЖЕНИЯТА ИМ - Google Patents

РТХ-ЧУВСТВИТЕЛНИ g-ПРОТЕИНИ, МЕТОД ЗА ТЯХНОТО ПРОИЗВОДСТВО И ПРИЛОЖЕНИЯТА ИМ Download PDF

Info

Publication number
BG103238A
BG103238A BG103238A BG10323899A BG103238A BG 103238 A BG103238 A BG 103238A BG 103238 A BG103238 A BG 103238A BG 10323899 A BG10323899 A BG 10323899A BG 103238 A BG103238 A BG 103238A
Authority
BG
Bulgaria
Prior art keywords
protein
human
nucleic acid
acid sequence
subunit
Prior art date
Application number
BG103238A
Other languages
Bulgarian (bg)
English (en)
Inventor
Winfried Siffert
Original Assignee
Winfried Siffert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Winfried Siffert filed Critical Winfried Siffert
Publication of BG103238A publication Critical patent/BG103238A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
BG103238A 1996-09-13 1999-03-11 РТХ-ЧУВСТВИТЕЛНИ g-ПРОТЕИНИ, МЕТОД ЗА ТЯХНОТО ПРОИЗВОДСТВО И ПРИЛОЖЕНИЯТА ИМ BG103238A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19637518A DE19637518A1 (de) 1996-09-13 1996-09-13 PTX-sensitive G-Proteine, ihre Herstellung und Verwendung
PCT/EP1997/004709 WO1998011212A1 (de) 1996-09-13 1997-08-29 Ptx-sensitive g-proteine, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
BG103238A true BG103238A (bg) 2000-06-30

Family

ID=7805651

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103238A BG103238A (bg) 1996-09-13 1999-03-11 РТХ-ЧУВСТВИТЕЛНИ g-ПРОТЕИНИ, МЕТОД ЗА ТЯХНОТО ПРОИЗВОДСТВО И ПРИЛОЖЕНИЯТА ИМ

Country Status (22)

Country Link
US (1) US6251853B1 (cs)
EP (1) EP0931145A1 (cs)
JP (1) JP2001501811A (cs)
KR (1) KR20000036058A (cs)
CN (1) CN1230222A (cs)
AU (1) AU4619297A (cs)
BG (1) BG103238A (cs)
BR (1) BR9711475A (cs)
CA (1) CA2265467A1 (cs)
CZ (1) CZ73499A3 (cs)
DE (1) DE19637518A1 (cs)
EA (1) EA199900253A1 (cs)
EE (1) EE9900092A (cs)
HU (1) HUP9904110A3 (cs)
IL (1) IL128746A0 (cs)
IS (1) IS4987A (cs)
NO (1) NO991227D0 (cs)
PL (1) PL332417A1 (cs)
SK (1) SK34099A3 (cs)
TR (1) TR199900500T2 (cs)
WO (1) WO1998011212A1 (cs)
ZA (1) ZA978220B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19619362A1 (de) * 1996-05-14 1997-11-20 Basf Ag Verwendung einer Genveränderung im Gen für humanes G-Protein beta-3-Untereinheit zur Diagnostik von Erkrankungen
WO1999058669A1 (en) * 1998-05-11 1999-11-18 Axys Pharmaceuticals, Inc. Rhoh genes and their uses
AU6079999A (en) * 1998-09-10 2000-04-03 Winfried Siffert Gene modification in the gene for the die gbeta3-sub-unit of human g-protein
FR2803525B1 (fr) * 2000-01-06 2002-05-03 Sod Conseils Rech Applic Inhibiteur de la transduction des signaux des proteines g heterotrimeriques associe a un agent anti-hypertenseur dans le traitement de l'hypertension arterielle
WO2001057246A1 (de) * 2000-02-03 2001-08-09 Winfried Siffert VERWENDUNG EINER GENVERÄNDERUNG IM GEN FÜR DIE β3-UNTEREINHEIT DES HUMANEN G-PROTEINS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587561A (en) 1995-07-28 1996-12-24 Budayr; Mahdi Stethoscope shield
DE19619362A1 (de) * 1996-05-14 1997-11-20 Basf Ag Verwendung einer Genveränderung im Gen für humanes G-Protein beta-3-Untereinheit zur Diagnostik von Erkrankungen

Also Published As

Publication number Publication date
IS4987A (is) 1999-02-26
PL332417A1 (en) 1999-09-13
DE19637518A1 (de) 1998-04-09
HUP9904110A3 (en) 2001-09-28
US6251853B1 (en) 2001-06-26
NO991227L (no) 1999-03-12
AU4619297A (en) 1998-04-02
EP0931145A1 (de) 1999-07-28
CZ73499A3 (cs) 1999-07-14
CA2265467A1 (en) 1998-03-19
HUP9904110A2 (en) 2000-07-28
WO1998011212A1 (de) 1998-03-19
CN1230222A (zh) 1999-09-29
IL128746A0 (en) 2000-01-31
BR9711475A (pt) 1999-08-24
NO991227D0 (no) 1999-03-12
EA199900253A1 (ru) 1999-10-28
JP2001501811A (ja) 2001-02-13
ZA978220B (en) 1999-03-12
EE9900092A (et) 1999-10-15
SK34099A3 (en) 2000-05-16
KR20000036058A (ko) 2000-06-26
TR199900500T2 (xx) 1999-06-21

Similar Documents

Publication Publication Date Title
US6524799B1 (en) DNA encoding sparc-related proteins
Chinnery et al. The mitochondrial ND6 gene is a hot spot for mutations that cause Leber's hereditary optic neuropathy
US7063958B1 (en) Nucleic acids db, the receptor for leptin
US6803448B1 (en) GBS toxin receptor
US20020106655A1 (en) Human GPCR proteins
JP2000505301A (ja) Ｃ−ｃ ｃｋｒ−５，ｃｃ−ケモカインレセプタ、その誘導体及びこれらの利用
AU7713098A (en) Ntn-2 member of tnf ligand family
Janssen et al. Connexin32 gene mutations in X-linked dominant Charcot-Marie-Tooth disease (CMTX1)
US20160282350A1 (en) Methods of diagnosing cancer
BG103238A (bg) РТХ-ЧУВСТВИТЕЛНИ g-ПРОТЕИНИ, МЕТОД ЗА ТЯХНОТО ПРОИЗВОДСТВО И ПРИЛОЖЕНИЯТА ИМ
US6566096B2 (en) Mammalian EDG-7 receptor homologs
US20020077309A1 (en) Diagnostics and therapeutics for pancreatic disorders
BG63214B1 (bg) Приложение на мутация в гена на човешката g-протеинова бета 3-субединица за диагностициране на заболявания
JPH10337189A (ja) 新規化合物
JPH09508267A (ja) 自然抵抗性結合マクロファージタンパク質およびその使用法
JP2002300892A (ja) 神経細胞付着スプライシング変種
US20030022186A1 (en) Novel human G-protein coupled receptor, hgprbmy18, expressed highly in pituitary gland and colon carcinoma cells
JPH10304883A (ja) 新規化合物
US20030054444A1 (en) Novel human G-protein coupled receptor, HGPRBMY8, expressed highly in brain
EP1308458A1 (en) New polynucleotides and polypeptides of the CX26 gene
Maves et al. Cloning and characterization of the cDNA encoding guinea-pig properdin: a comparison of properdin from three species
JP2004041175A (ja) ヒトｌｉｇ−１相同体（ｈｌｉｇ−１）
CN1279716A (zh) 人HsgⅢ基因
US7619079B2 (en) Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof
CN1375503A (zh) 雄激素受体复合物相关蛋白